FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer.
Raschzok N, Stintzing S, Heinemann V, Rauch G, Ricke J, Guckenberger M, Kurreck A, Alig AHS, Stahler A, Bullinger L, Schmelzle M, Schöning W, Lurje G, Krenzien F, Haase O, Rau B, Gebauer B, Sauer IM, Pratschke J, Modest DP.
Raschzok N, et al. Among authors: haase o.
BMC Cancer. 2022 Apr 2;22(1):359. doi: 10.1186/s12885-022-09422-6.
BMC Cancer. 2022.
PMID: 35366831
Free PMC article.
Clinical Trial.